본문 바로가기

알레르기성 기도 질환에서 줄기세포 유래 세포외 소포체의 응용

Application of Stem Cell-Derived Extracellular Vesicles in Allergic Airway Diseases

문서 유형
연구출판물 · 학술지 논문
등재
KCI
저널
Journal of Rhinology27(1) · pp.1 · 2020
피인용
KCI 1
ISSN
1229-1498

저자

  1. 김성동제1저자Pusan National University
  2. 조규섭교신저자부산대학교

초록

Mesenchymal stem cells (MSCs) have been reported to be promising candidates for the treatment of allergic airway diseases. However, MSCs themselves have several problems including immune rejection, risk of aneuploidy, difficulty of handling, and tumorigenicity. An increasing number of studies demonstrated that administration of conditioned media or extracellular vesicles (EVs) released by MSCs is as effective as the MSCs themselves in suppression of allergic airway inflammation. EVs can exert their effects by delivering their contents such as proteins, mRNAs, and microRNAs to recipient cells. Furthermore, the administration of MSCs-derived EVs may reduce potential safety risks associated with stem cell therapy, suggesting that MSCs-derived EVs may be a promising alternative to cell therapy for allergic airway diseases. This review examines the current understanding of the immunomodulatory properties of MSCs-derived EVs and its therapeutic implication for allergic airway diseases.

키워드

Mesenchymal stem cellsExtracellular vesiclesAllergic rhinitisAsthmaImmunosuppression.

식별자

KCI
ART002592177